Back to search

Article

Evolution of COVID-19 patients treated with ImmunoFormulation, a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort study

2021-01-13

Abstract excerpt

<h4>Background: </h4> Although a vast knowledge has already been gathered on the pathophysiology of COVID-19, there are still limited, non-optimal treatment options. In this context, agents that can act on prophylaxis or as adjuvants to the therapies are of high value. <h4>Methods: </h4> In this paper, we describe a multicentre, retrospective, observational study to describe the course of SARS-CoV-2 disease in pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9843942-3192-52d7-bfb8-be1b6d26835a
DOI
10.21203/rs.3.rs-133532/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evolution of COVID-19 patients treated with ImmunoFormulation, a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort studyDOI 10.21203/rs.3.rs-133532/v2
Select a neighboring publication to make it the new centre.